Who
Mir A. Imran
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Rani Therapeutics Holdings.
In numbers
- Trades disclosed
- 25
- Buys
- 2
- Sells
- 1
- Bought
- $1.3M
- Sold
- $854K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Feb 2022
- Last trade
- 21 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jul 2026filed 23 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Bought | $25K36,000 at $0.69 | filing |
| 21 Jul 2026filed 23 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Bought | $25K36,000 at $0.69 | filing |
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,083,334 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Bought | $1.3M2,083,334 at $0.61 | filing |
| 28 May 2025filed 30 May 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —101,276 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 | filing |
| 29 May 2024filed 30 May 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —101,276 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 | filing |
| 25 May 2023filed 30 May 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 at $0.00 | filing |
| 23 Aug 2022filed 25 Aug 2022 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code C | —7,694 at $0.00 | filing |
| 23 Aug 2022filed 25 Aug 2022 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code C | —7,694 at $0.00 | filing |
| 23 Aug 2022filed 25 Aug 2022 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code C | —7,694 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Sold | $747K71,042 at $10.51 | filing |
| 17 Aug 2022filed 19 Aug 2022 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Sold | $107K9,210 at $11.62 | filing |
| 25 May 2022filed 27 May 2022 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,416 at $0.00 | filing |
| 7 Mar 2022filed 10 Mar 2022 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code C | —2,309,490 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.